Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.
Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.
复制标题
DOI:
--
复制
发表时间:
2000-02
期刊:
影响因子:
11.2
通讯作者:
D. Duda;M. Sunamura;Lucian Lozonschi;T. Kodama;Shinichi Egawa;Gaku Matsumoto;H. Shimamura;K. Shibuya;Kazunori Takeda;Seiki Matsuno
中科院分区:
文献类型:
--
作者:
D. Duda;M. Sunamura;Lucian Lozonschi;T. Kodama;Shinichi Egawa;Gaku Matsumoto;H. Shimamura;K. Shibuya;Kazunori Takeda;Seiki Matsuno
As an antitumor agent, interleukin-12 (IL-12) has been revealed to be a key regulator of the immune response, particularly that involving CTL and natural killer (NK) cells. We report herein the antiangiogenesis effect of IL-12 on human as well as murine tumors in NK-depleted severe-combined immunodeficient mice using fibroblasts genetically engineered to secrete this cytokine. Although the in vitro growth of tumor cells was not affected by the presence of IL-12, coinoculation of IL-12-secreting fibroblasts strongly inhibited tumor growth in immunodeficient mice. The neovascularization surrounding the tumor was remarkably inhibited in the area in which the IL-12-secreting fibroblasts were implanted, resulting in the suppression of tumor growth. Lectin staining in tumor sample sections also showed a significant reduction in the number of vessels. The RNA expression of IFN-gamma and its inducible antiangiogenic chemokine IFN gamma-inducible protein 10 was stimulated in endothelial cells cultured with IL-12. It was also found that IL-12 down-regulated the expression of the endothelial cell mitogens vascular endothelial growth factor and basic fibroblast growth factor. The antitumor effects of IL-12 were accompanied by interesting histological changes consisting of a high degree of keratinization and apoptosis and a decrease in the proliferation rate of human tumors and extensive necrosis in the murine ones.